Influence of the Type of Basal Insulin and Other Variables on Clinical Outcomes in Children with Newly Diagnosed Type 1 Diabetes

Table 2

HbA1c, change in HbA1c, achievement of goal, and total mean daily insulin dose at each time point.

	0 months	3 months	6 months	12 months
Glargine
HbA1c	11.8 ± 1.9	6.78 ± 0.93	6.96 ± 1.66	7.98 ± 2.00
Change in HbA1c	N/A	4.97 ± 1.97	4.86 ± 2.59	3.81 ± 2.74
Achievement of goal HbA1c	0%	76%	76%	42%
Mean daily insulin dose (units/kg)	0.70 ± 0.14	0.59 ± 0.15	0.60 ± 0.17	0.69 ± 0.19
Detemir
HbA1c	11.5 ± 2.4	7.03 ± 1.08	6.27 ± 0.93	7.30 ± 1.34
Change in HbA1c	N/A	4.51 ± 2.02	5.27 ± 2.46	4.24 ± 2.48
Achievement of goal HbA1c	7%	68%	93%	55%
Mean daily insulin dose (units/kg)	0.66 ± 0.16	0.61 ± 0.16	0.60 ± 0.18	0.66 ± 0.24